Literature DB >> 2064471

Delayed presentation and treatment of popliteal artery embolism.

R P Cambria1, B A Ridge, D C Brewster, A C Moncure, R C Darling, W M Abbott.   

Abstract

In the course of reviewing a 10-year experience with popliteal artery embolism (PAE), two distinct patterns of clinical presentation were identified. In addition to those patients presenting with typical acute (symptom duration less than 7 days) arterial ischemia, a second group was identified who presented with more chronic symptoms. The present study was conducted to contrast the clinical factors and treatment of these two temporal patterns of presentation with PAE. Sixty PAEs in 58 patients were documented by the combination of angiography and/or exploration of the popliteal artery. Acute presentation (AP) was seen in 41 (68%) of these and delayed presentation (DP) was noted in 19 (32%) patients. Delayed presentation patients typically presented with a history of sudden onset of claudication or rest pain and a median symptom duration of 30 days. Eighty per cent of AP patients presented with immediately threatened limbs. Angiography was generally diagnostic of chronic popliteal embolism. In the acute group, 90% were treated with embolectomy alone, while 20% of the DP group required bypass grafting. However in two thirds of the DP group, embolectomy alone performed through a direct popliteal approach was possible. Current results with overall limb salvage (92%) and mortality (7%) represents a substantial improvement compared to the authors' previous experience with PAE. The current study suggests that as many as one third of patients with popliteal artery embolism may present in delayed fashion with chronic symptoms. Furthermore most of these patients can be treated with direct popliteal embolectomy alone with favorable results.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064471      PMCID: PMC1358413          DOI: 10.1097/00000658-199107000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Late peripheral arterial embolectomy.

Authors:  J H OLWIN; W S DYE; O C JULIAN
Journal:  AMA Arch Surg       Date:  1953-04

2.  Battle Injuries of the Arteries in World War II : An Analysis of 2,471 Cases.

Authors:  M E Debakey; F A Simeone
Journal:  Ann Surg       Date:  1946-04       Impact factor: 12.969

3.  Intraoperative video angioscopy compared with arteriography during peripheral vascular operations.

Authors:  G H White; R A White; G E Kopchok; S R Klein; S E Wilson
Journal:  J Vasc Surg       Date:  1987-11       Impact factor: 4.268

4.  Delayed arterial embolectomy.

Authors:  M A Naqvi; D H MacKenzie; L S Allen; D Gaum
Journal:  Can J Surg       Date:  1974-09       Impact factor: 2.089

5.  Arterial embolectomy in the leg. Results in a referral hospital.

Authors:  J Kendrick; B W Thompson; R C Read; G S Campbell; R C Walls; R E Casali
Journal:  Am J Surg       Date:  1981-12       Impact factor: 2.565

6.  Arterial embolism.

Authors:  R C Darling; W G Austen; R R Linton
Journal:  Surg Gynecol Obstet       Date:  1967-01

7.  Arterial embolization: problems of source, multiplicity, recurrence, and delayed treatment.

Authors:  J P Elliott; J H Hageman; E Szilagyi; V Ramakrishnan; J J Bravo; R F Smith
Journal:  Surgery       Date:  1980-12       Impact factor: 3.982

8.  Differential management of acute peripheral arterial ischemia.

Authors:  W A Dale
Journal:  J Vasc Surg       Date:  1984-03       Impact factor: 4.268

9.  Embolism of the popliteal artery.

Authors:  W M Abbott; C McCabe; R D Maloney; L S Wirthlin
Journal:  Surg Gynecol Obstet       Date:  1984-12

10.  Arterial embolectomy: a 34-year experience with 400 cases.

Authors:  T Panetta; J E Thompson; C M Talkington; W V Garrett; B L Smith
Journal:  Surg Clin North Am       Date:  1986-04       Impact factor: 2.741

View more
  1 in total

1.  Should embolectomy be performed in late acute lower extremity arterial occlusions?

Authors:  Hikmet Iyem; M Nesimi Eren
Journal:  Vasc Health Risk Manag       Date:  2009-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.